APA BIPOLAR DISORDER GUIDELINE LISTS LITHIUM AS FIRST CHOICE
Executive Summary
APA BIPOLAR DISORDER GUIDELINE LISTS LITHIUM AS FIRST CHOICE line of therapy, but notes that the newer drugs valproic acid and carbamazapine are also good first choices of treatment, depending on the patient. The American Psychiatric Association, which released its first guideline "for the treatment of patients who have had at least one episode of mania (i.e. Bipolar I Disorder)," said at a Dec. 7 press conference that the guidelines are designed to help psychiatrists diagnose and treat the disease, also known as manic-depressive illness. Bipolar Disorder occurs in approximately 3 mil. American adults, or 1.6% of the U.S. population, according to a recent National Depressive & Manic Depressive Association survey.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth